LIXTE Names Sidney Braun CEO of Liora Technologies

Boca Raton, FL, February 18, 2026 (Globe Newswire) -- LIXTE Biotechnology Holdings, Inc., a clinical-stage oncology company developing small-molecule cancer therapies and radiotherapy technologies, announced the appointment of Sidney Braun as Chief Executive Officer of its European subsidiary, Liora Technologies Europe Ltd.. Braun brings more than two decades of healthcare operational and strategic experience and previously played a key role in establishing Liora and facilitating LIXTE’s acquisition of its assets in November 2025 from Orbit Capital, Inc.

Read full article here.